[Risk evaluation and management of the pregnant asthmatic].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001249:Asthma / Q000503:physiopathology / Q000628:therapy*; D004205:Cromolyn Sodium / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D007665:Ketotifen / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D011453:Prostaglandins / Q000502:physiology; D012306:Risk; D013806:Theophylline / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D011453:Prostaglandins; D013806:Theophylline; D004205:Cromolyn Sodium; D006854:Hydrocortisone; D007665:Ketotifen
Appréciation du risque et conduite à tenir chez l'asthmatique enceinte.